TLR4 and metabolic dysfunction-associated steatohepatitis: Together, our translational results support the potential role for fEVs as key players in NAFLD progression towards NASH, by acting from the gut to the liver, and underscore nmMLCK and TLR4 as potential key targets for NASH resolution and fibrosis.